FDA issued a Warning Letter to Cambrex Profarmaco Milano Srl on 8/12/2009 for a previous inspection.
483 Cambrex Profarmaco Milano Srl May 2017

483 Cambrex Profarmaco Milano Srl May 2017

Margaret Annes FDA, Temar Williams FDA$119.00 - Available Now

FDA investigators audited the Cambrex Profarmaco Milano Srl - Paullo, Italy facility and issued inspectional observations (via FDA 483) on 19 May 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 19 May 2017
  • Location: Paullo, Italy
  • FEI: 3003723076
Add To Cart
Cambrex Profarmaco Milano Srl FDA inspection 483 May 2017Add To Cart